Account
GroupM acquires The Exchange Lab
MUMBAI: WPP’s GroupM has added The Exchange Lab and its proprietary programmatic marketing technology, Proteus, to its portfolio by acquisition of the company.
The Exchange Lab will become a core component of Connect, part of GroupM, to expand its multi-platform (meta-DSP) approach.
The Exchange Lab is a programmatic marketing solutions company with a unique technology that enables a complete view of all programmatic channels and partners via Proteus. The integration of Proteus by GroupM will expand the efficient and objective measurement and allocation of marketing budgets across any and all programmatic partners, including GroupM’s own proprietary media properties.
Co-founded in 2007 by James Aitken and Tim Webster, The Exchange Lab has approximately 130 employees working in offices in London, New York, Chicago, Singapore, and Toronto, serving 700 clients this year, including Virgin Holidays, Volkswagen, A&W, Glasses Direct and Vue Entertainment.
In concert with the acquisition, Aitken will be stepping down from his role as CEO to pursue outside investment interests. Moving forward, executive chairman, Chris Dobson, will take the role of CEO, working closely with Tim Webster who continues as chief strategy officer. Dobson will report directly to GroupM Connect global CEO Rudiger Wanck.
The Exchange Lab will operate globally as an agnostic business layer within Connect, while also continuing to service clients independently. Connect is GroupM’s worldwide digital organisation bringing together data, operations and technology across search, programmatic, social, mobile and all other real time and biddable media. With more than 2,000 experts working across more than 50 countries, Connect provides real time media investment management on an unprecedented scale.
“The Exchange Lab’s value proposition for an all-in-one solution across all digital media and devices and their commitment to building the absolute best technology to solve complexity for clients aligns precisely with the goals of Connect,” said Wanck. “The impetus behind the creation of Connect is to provide agnostic real time media investment management across all technologies, data and inventory. Adding The Exchange Lab’s talent and proprietary technology accelerates our development and directly benefits the clients of GroupM’s agencies. Likewise, GroupM’s unparalleled scale and innovative media partnerships will terrifically enhance The Exchange Lab’s client services. I greatly admire The Exchange Lab’s accomplishments and look forward to working closely with Chris Dobson and his team.”
“We chose GroupM for the opportunity to join the world’s leading media investment group who is also the industry’s thought leader on digital advertising and the digitisation of traditional media. This will propel The Exchange Lab to new heights, and GroupM’s culture will allow us to continue marketplace innovation driven by our entrepreneurial spirit. Together with Connect, we will continue to develop the absolute best real time media technology to reach and engage audiences for brands,” said The Exchange Lab CEO Chris Dobson.
“I am extremely proud of the team and technology we built at The Exchange Lab and look forward to watching it grow within GroupM,” said The Exchange Lab co-founder and former CEO James Aitken. “Chris Dobson played a major role shaping the development of the Exchange Lab and his extensive senior leadership experience with BBC Worldwide, Viacom and Microsoft makes him the perfect leader to take the business to its next stage of success within GroupM.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
